AK

Aneesh Kochumalayil Shaji

Active Director Director DIN 09236122
DIN 09236122 First appointment Jul 2021 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Aneesh Kochumalayil Shaji

Data last updated:

Aneesh Kochumalayil Shaji is a Director at N7 Biotecor Private Limited (since 2021). The company operates in Research & Development.

DIN 09236122
Primary Designation Director
Industry Research & Development
First Appointment 12 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
N7 Biotecor Private Limited U73100KL2021PTC069791
Director12 Jul 20212021Active

Board colleagues of Aneesh Kochumalayil Shaji

NameDINCompanyDesignation
Chamappoyil Nandagopal09236133N7 Biotecor Private LimitedDirector

Directorship timeline

Open interactive timeline →
N7 Biotecor Private Limited
Premium access

Shareholding and investment profile for Aneesh Kochumalayil Shaji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aneesh Kochumalayil Shaji

Aneesh Kochumalayil Shaji currently holds 1 directorship: N7 Biotecor Private Limited (Director, since 12 Jul 2021).

Aneesh Kochumalayil Shaji was first appointed on 12 Jul 2021 as Director at N7 Biotecor Private Limited.

The current boards of Aneesh Kochumalayil Shaji's companies include Chamappoyil Nandagopal (N7 Biotecor Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available